Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib

doi:10.3748/wjg.v16.i28.3592

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2709)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

280

HTML

2162

Figures (1-5)

267

Sum=2709

Jul 28, 2010 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jul 28, 2010; 16(28): 3592-3596
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3592

Full Size Figure Download Figure

Figure 2 Radiologic assessment of the primary liver tumors and the thoracic metastasis before initiation of sorafenib therapy in September 2007. A: Multiple hepatocellular carcinoma lesions (maximum diameter 6 cm) in computed tomography scan of the liver; B: Thoracic metastasis of the 2nd rib (maximum diameter 8.00 cm × 9.19 cm).

Citation: Wich C, Agaimy A, Strobel D, Wissniowski TT, Hartmann A, Ocker M. Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib. World J Gastroenterol 2010; 16(28): 3592-3596
URL: https://www.wjgnet.com/1007-9327/full/v16/i28/3592.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i28.3592